Explore more topics
SEC Form 4 research

Sierra Oncology, Inc. insider transactions

Inspect Sierra Oncology, Inc.'s public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-15T08:02:39.132Z

Issuer CIK
0001290149
Reporting owners
66
Officers and directors
25
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Show the table · 0 rows, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Show the table · 26 rows, 3 columns

Scroll sideways to compare all columns. Select a heading to sort.

Vivo Ventures Fund VII, L.P.000150916039
Topper James N0001341382967
Richardson Joshua00017937621
Turner William D.000181968810
You Angie00016476643
Vivo Opportunity, LLC0001728970104
Klencke Barbara00016476479
Sinclair Andrew00017624516
Collard Craig A000136355814
DILLY STEPHEN GEORGE000138914732
Thompson Peter A.0001357522111
Vivo Capital Fund IX, L.P.000175011717
Aggarwal Gaurav00015519654
Allen Andrew R000137453912
Cha Albert000139790631
Chapman Wendy00016476523
Glover Nicholas00015788881
ISALY SAMUEL D0001055949417
Lovejoy Chandra D000150942015
ORBIMED ADVISORS LLC00010559511,020
OrbiMed Private Investments V, LP00015893161
Rodigueza Wendi00016476633
Thomson Mary Christina00012956747
Vivo Capital IX, LLC000175069817
Vivo Ventures VII Affiliates Fund, L.P.000153830939
VIVO VENTURES VII, LLC000156502042

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.